Health Canada is advising Canadians that Mylan Pharmaceuticals ULC has
begun a voluntary recall of certain lots of its Mylan-Nitro Sublingual
Spray 0.4 mg Per Metered Dose to the retail level. The recall is a
result of the product potentially missing the "dip tube," which is part
of the pump component. A missing "dip tube" could pose a problem with
the delivery of nitroglycerin to the patient.
Health Canada had previously informed Canadians
about this issue, but the recall was initially delayed due to the
possibility of creating a shortage of this medically necessary heart
drug on the Canadian market.
Health Canada would also like to inform Canadians that Mylan
Pharmaceuticals ULC is now releasing product from a different lot that
had been set aside and now verified to have a "dip tube" by the company.
Consumers should verify that there is a checkmark sticker on the
product's canister closure and carton, which demonstrates that it has
the "dip tube".
In order to help ensure ongoing supply of the product, the company is
advising consumers to continue using their current canister and only
refill their prescription once one-third of their spray (70-75 doses)
has been used.
Consumers should consult their pharmacist or healthcare practitioner if
they have any concerns regarding the use of this product and report any
adverse events to Health Canada.
No comments:
Post a Comment